XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Clinical trial NCT00272051 · COMPLETED

Trial details

NCT number: NCT00272051
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastases Colorectal Neoplasms Colorectal Carcinoma

Start date: 2002-07-01
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.